Champions Oncolog (CSBR)

$6.30 -0.09 (-1.41%)
Market Cap 86.80M
Revenue (ttm) 56.94M
Net Income (ttm) 4.70M
EPS (ttm) N/A
PE Ratio 31.95
Forward PE N/A
Profit Margin 8.25%
Debt to Equity Ratio 0.00
Volume 14,100
Avg Vol 32,940
Day's Range N/A - N/A
Shares Out 13.78M
Stochastic %K 17%
Beta 0.55
Analysts Strong Sell
Price Target $12.00

Company Profile

Champions Oncology, Inc., a technology-enabled research company, provides technology solutions for drug discovery and development in the United States. The company, through its Tumorgraft technology platform, provides personalized cancer care based upon the implantation of human tumors in immune-deficient mice. It also offers translational oncology solutions that utilizes its technology platform to provide research services that assist in the drug development process of pharmaceutical and biotec...

Industry: Biotechnology
Sector: Healthcare
Phone: 201 808 8400
Address:
One University Plaza, Suite 307, Hackensack, United States
JackieFuqua408
JackieFuqua408 Sep. 21 at 6:37 AM
$CSBR Biotech with niche focus. Thin volume trading. No clear pattern emerging.
0 · Reply
RadioIsotope25
RadioIsotope25 Sep. 18 at 9:47 PM
$RADX Can’t miss webinar for Radiopharmaceutical investors… $ATNM $CLRB $LNTH $CSBR
1 · Reply
GMExAPE
GMExAPE Sep. 17 at 9:13 PM
RMFC stock has 5X potential, shorts at zero borrow and the 3m float is locked. Very undervalued here - No dilution - Catalysts coming - Just reported record financials and added a new store a few weeks ago. $TURB $CSBR $IVVD $CGTX $YXT watching close
2 · Reply
indievestments
indievestments Sep. 15 at 7:29 PM
$CSBR trading like they got Corellia funding. I guess we'll see tonight.
1 · Reply
S2K_TP
S2K_TP Sep. 14 at 8:52 PM
🚨 Major Monday's earnings releases: @everyone $CODA before bell $OPTT after bell $HITI after bell $PLAY after bell $CSBR after bell
0 · Reply
RadioIsotope25
RadioIsotope25 Sep. 12 at 12:33 PM
$RADX Lantheus is an aggregator in this space. $RADX $CSBR $LNTH
0 · Reply
RadioIsotope25
RadioIsotope25 Sep. 11 at 4:53 PM
$RADX Significant Radiopharma deals in 2025 $CSBR $CLRB $NVS
0 · Reply
RadioIsotope25
RadioIsotope25 Sep. 11 at 1:30 AM
$RADX “We are pleased to make a strategic investment in RAD and partner with them to further expand our innovative pipeline,” said Brian Markison, Chief Executive Officer of Lantheus. “Radiopharmaceutical theranostics are changing the way cancer is diagnosed and treated, yet we still have more work to do and are inspired to further advance this field with these two preclinical oncology assets. $LNTH $ATNM $CSBR
3 · Reply
Ned__ryerson
Ned__ryerson Aug. 26 at 9:57 PM
$CSBR this thing is starting to stink again. Oh well, I do wish they would get their shit together.
0 · Reply
indievestments
indievestments Aug. 25 at 2:50 PM
$CSBR 20k in the premarket?
0 · Reply
Latest News on CSBR
Champions Oncology, Inc. (CSBR) Q1 2026 Earnings Call Transcript

Sep 15, 2025, 6:35 PM EDT - 19 days ago

Champions Oncology, Inc. (CSBR) Q1 2026 Earnings Call Transcript

CORRECTION: Champions Oncology Reports Quarterly Revenue of $14.0 Million

Sep 15, 2025, 4:50 PM EDT - 19 days ago

CORRECTION: Champions Oncology Reports Quarterly Revenue of $14.0 Million

Champions Oncology Reports Record Quarterly Revenue of $14.0 Million

Sep 15, 2025, 3:55 PM EDT - 19 days ago

Champions Oncology Reports Record Quarterly Revenue of $14.0 Million

Champions Oncology to Announce First Quarter Financial Results on Monday, September 15, 2025

Sep 10, 2025, 4:30 PM EDT - 24 days ago

Champions Oncology to Announce First Quarter Financial Results on Monday, September 15, 2025

Champions Oncology (CSBR) Q4 2025 Earnings Call Transcript

Jul 25, 2025, 7:55 AM EDT - 2 months ago

Champions Oncology (CSBR) Q4 2025 Earnings Call Transcript

Champions Oncology Reports Record Annual Revenue of $57 Million

Jul 23, 2025, 4:00 PM EDT - 2 months ago

Champions Oncology Reports Record Annual Revenue of $57 Million

Champions Oncology to Announce Fourth Quarter and Year-End Financial Results on Wednesday, July 23, 2025

Jul 21, 2025, 8:30 AM EDT - 2 months ago

Champions Oncology to Announce Fourth Quarter and Year-End Financial Results on Wednesday, July 23, 2025

Champions Oncology Announces Appointment of New CEO

Jul 18, 2025, 8:30 AM EDT - 2 months ago

Champions Oncology Announces Appointment of New CEO

Champions Oncology Launches Radiopharmaceutical Services Platform, Expands Isotope License, and Screens More Than 30 PDX Models

Jul 8, 2025, 8:30 AM EDT - 3 months ago

Champions Oncology Launches Radiopharmaceutical Services Platform, Expands Isotope License, and Screens More Than 30 PDX Models

Champions Oncology: Biological IP Is The Real Asset - Not Preclinical Services

Jun 16, 2025, 2:47 PM EDT - 3 months ago

Champions Oncology: Biological IP Is The Real Asset - Not Preclinical Services

Champions Oncology Obtains Radioactive Materials License to Advance Comprehensive Radiotherapeutic Studies In-House

Apr 28, 2025, 9:45 AM EDT - 5 months ago

Champions Oncology Obtains Radioactive Materials License to Advance Comprehensive Radiotherapeutic Studies In-House

Champions Oncology's Data Platform Gains Momentum through a Strategic Collaboration with Turbine

Apr 24, 2025, 8:00 AM EDT - 5 months ago

Champions Oncology's Data Platform Gains Momentum through a Strategic Collaboration with Turbine

Champions Oncology, Inc. (CSBR) Q3 2025 Earnings Call Transcript

Mar 11, 2025, 8:07 PM EDT - 7 months ago

Champions Oncology, Inc. (CSBR) Q3 2025 Earnings Call Transcript

Champions Oncology Reports Record Quarterly Revenue of $17.0 Million Record Net Income of $4.5 Million

Mar 11, 2025, 3:55 PM EDT - 7 months ago

Champions Oncology Reports Record Quarterly Revenue of $17.0 Million Record Net Income of $4.5 Million

Champions Oncology to Announce Third Quarter Financial Results on Tuesday, March 11, 2025

Mar 6, 2025, 4:00 PM EST - 7 months ago

Champions Oncology to Announce Third Quarter Financial Results on Tuesday, March 11, 2025

Champions Oncology Announces 17 Abstracts Accepted for Presentation at the 2025 American Association for Cancer Research Annual Meeting

Feb 18, 2025, 9:00 AM EST - 8 months ago

Champions Oncology Announces 17 Abstracts Accepted for Presentation at the 2025 American Association for Cancer Research Annual Meeting

Champions Oncology Enhances Clinical Bioanalytical Services Portfolio with New Technology and Additional Leadership

Jan 8, 2025, 8:00 AM EST - 9 months ago

Champions Oncology Enhances Clinical Bioanalytical Services Portfolio with New Technology and Additional Leadership

Champions Oncology: Right Point To Own In The Cycle Thanks To Operating Efficiencies

Dec 27, 2024, 9:00 AM EST - 10 months ago

Champions Oncology: Right Point To Own In The Cycle Thanks To Operating Efficiencies

Champions Oncology, Inc. (CSBR) Q2 2025 Earnings Call Transcript

Dec 11, 2024, 6:02 PM EST - 10 months ago

Champions Oncology, Inc. (CSBR) Q2 2025 Earnings Call Transcript

Champions Oncology Reports Quarterly Revenue of $13.5 Million Adjusted EBITDA of $1.1 Million

Dec 11, 2024, 4:00 PM EST - 10 months ago

Champions Oncology Reports Quarterly Revenue of $13.5 Million Adjusted EBITDA of $1.1 Million

Champions Oncology to Announce Second Quarter Financial Results on Wednesday, December 11, 2024

Dec 5, 2024, 4:30 PM EST - 10 months ago

Champions Oncology to Announce Second Quarter Financial Results on Wednesday, December 11, 2024

Champions Oncology Announces Agreement with Weill Cornell Medicine

Oct 16, 2024, 10:55 AM EDT - 1 year ago

Champions Oncology Announces Agreement with Weill Cornell Medicine

Champions Oncology, Inc. (CSBR) Q1 2025 Earnings Call Transcript

Sep 11, 2024, 8:52 PM EDT - 1 year ago

Champions Oncology, Inc. (CSBR) Q1 2025 Earnings Call Transcript

Champions Oncology Reports Quarterly Revenue of $14.1 Million Adjusted EBITDA of $2.0 Million

Sep 11, 2024, 4:00 PM EDT - 1 year ago

Champions Oncology Reports Quarterly Revenue of $14.1 Million Adjusted EBITDA of $2.0 Million

Champions Oncology to Announce First Quarter Financial Results on Wednesday, September 11, 2024

Sep 9, 2024, 4:00 PM EDT - 1 year ago

Champions Oncology to Announce First Quarter Financial Results on Wednesday, September 11, 2024

Champions Oncology, Inc. (CSBR) Q4 2024 Earnings Call Transcript

Jul 18, 2024, 6:11 PM EDT - 1 year ago

Champions Oncology, Inc. (CSBR) Q4 2024 Earnings Call Transcript

Champions Oncology Reports Quarterly Revenue of $14.0 Million

Jul 18, 2024, 4:00 PM EDT - 1 year ago

Champions Oncology Reports Quarterly Revenue of $14.0 Million

Champions Oncology to Announce Fourth Quarter and Year-End Financial Results on Thursday, July 18, 2024

Jul 11, 2024, 4:05 PM EDT - 1 year ago

Champions Oncology to Announce Fourth Quarter and Year-End Financial Results on Thursday, July 18, 2024

Champions Oncology and Medicines Discovery Catapult Forge Partnership to Accelerate Radiopharmaceutical Therapeutics Development

Jun 4, 2024, 9:00 AM EDT - 1 year ago

Champions Oncology and Medicines Discovery Catapult Forge Partnership to Accelerate Radiopharmaceutical Therapeutics Development

Champions Oncology, Inc. (CSBR) Q3 2024 Earnings Call Transcript

Mar 12, 2024, 7:21 PM EDT - 1 year ago

Champions Oncology, Inc. (CSBR) Q3 2024 Earnings Call Transcript

Champions Oncology Reports Quarterly Revenue of $12.0 Million

Mar 12, 2024, 4:30 PM EDT - 1 year ago

Champions Oncology Reports Quarterly Revenue of $12.0 Million

Champions Oncology's US Laboratory has Acquired Distinguished CAP Accreditation

Mar 7, 2024, 9:00 AM EST - 1 year ago

Champions Oncology's US Laboratory has Acquired Distinguished CAP Accreditation

Champions Oncology to Announce Third Quarter Financial Results on Tuesday, March 12, 2024

Mar 6, 2024, 4:35 PM EST - 1 year ago

Champions Oncology to Announce Third Quarter Financial Results on Tuesday, March 12, 2024

Champions Oncology, Inc. (CSBR) Q2 2024 Earnings Call Transcript

Dec 12, 2023, 5:54 PM EST - 1 year ago

Champions Oncology, Inc. (CSBR) Q2 2024 Earnings Call Transcript

Champions Oncology Reports Quarterly Revenue of $11.6 Million

Dec 12, 2023, 4:00 PM EST - 1 year ago

Champions Oncology Reports Quarterly Revenue of $11.6 Million

Champions Oncology to Announce Second Quarter Financial Results on Tuesday, December 12, 2023

Dec 4, 2023, 4:30 PM EST - 1 year ago

Champions Oncology to Announce Second Quarter Financial Results on Tuesday, December 12, 2023

Champions Oncology's European Research Operations Site Receives ISO-9001:2015 Accreditation and ATS Certification

Nov 2, 2023, 8:30 AM EDT - 2 years ago

Champions Oncology's European Research Operations Site Receives ISO-9001:2015 Accreditation and ATS Certification

Champions Oncology Announces the Addition of Brady Davis as President

Oct 17, 2023, 8:30 AM EDT - 2 years ago

Champions Oncology Announces the Addition of Brady Davis as President

Champions Oncology, Inc. (CSBR) Q1 2024 Earnings Call Transcript

Sep 15, 2023, 1:34 PM EDT - 2 years ago

Champions Oncology, Inc. (CSBR) Q1 2024 Earnings Call Transcript

Champions Oncology Reports Quarterly Revenue of $12.6 Million

Sep 13, 2023, 4:00 PM EDT - 2 years ago

Champions Oncology Reports Quarterly Revenue of $12.6 Million

Champions Oncology to Announce First Quarter Financial Results on Wednesday, September 13, 2023

Sep 11, 2023, 4:00 PM EDT - 2 years ago

Champions Oncology to Announce First Quarter Financial Results on Wednesday, September 13, 2023

Champions Oncology Aannounces Remarkable Lineup of Speakers at Its Translational Oncology Symposium in Boston in September 2023

Aug 22, 2023, 8:30 AM EDT - 2 years ago

Champions Oncology Aannounces Remarkable Lineup of Speakers at Its Translational Oncology Symposium in Boston in September 2023

Champions Oncology Announces a Multi-Year Agreement and Strategic Collaboration with BioVolume to Transform Reproducibility in Preclinical Oncology Efficacy Studies

Aug 1, 2023, 8:45 AM EDT - 2 years ago

Champions Oncology Announces a Multi-Year Agreement and Strategic Collaboration with BioVolume to Transform Reproducibility in Preclinical Oncology Efficacy Studies

Champions Oncology, Inc. (CSBR) Q4 2023 Earnings Call Transcript

Jul 24, 2023, 6:34 PM EDT - 2 years ago

Champions Oncology, Inc. (CSBR) Q4 2023 Earnings Call Transcript

Champions Oncology Reports Quarterly Revenue of $13.1 Million

Jul 24, 2023, 4:00 PM EDT - 2 years ago

Champions Oncology Reports Quarterly Revenue of $13.1 Million

Champions Oncology to Announce Fourth Quarter and Year-End Financial Results on Monday, July 24, 2023

Jul 20, 2023, 4:00 PM EDT - 2 years ago

Champions Oncology to Announce Fourth Quarter and Year-End Financial Results on Monday, July 24, 2023

Champions Oncology Announces the Formation of Corellia AI, a Wholly Owned Biotech that Leverages Unique AI-Enabled Workflows for Novel Therapeutic Development

Apr 17, 2023, 8:30 AM EDT - 2 years ago

Champions Oncology Announces the Formation of Corellia AI, a Wholly Owned Biotech that Leverages Unique AI-Enabled Workflows for Novel Therapeutic Development

Champions Oncology Announces $5M Stock Repurchase Program

Apr 5, 2023, 9:50 AM EDT - 2 years ago

Champions Oncology Announces $5M Stock Repurchase Program

Champions Oncology, Inc. (CSBR) Q3 2023 Earnings Call Transcript

Mar 17, 2023, 3:52 PM EDT - 2 years ago

Champions Oncology, Inc. (CSBR) Q3 2023 Earnings Call Transcript

Champions Oncology Reports Quarterly Revenue of $12.8 Million

Mar 15, 2023, 3:50 PM EDT - 2 years ago

Champions Oncology Reports Quarterly Revenue of $12.8 Million

JackieFuqua408
JackieFuqua408 Sep. 21 at 6:37 AM
$CSBR Biotech with niche focus. Thin volume trading. No clear pattern emerging.
0 · Reply
RadioIsotope25
RadioIsotope25 Sep. 18 at 9:47 PM
$RADX Can’t miss webinar for Radiopharmaceutical investors… $ATNM $CLRB $LNTH $CSBR
1 · Reply
GMExAPE
GMExAPE Sep. 17 at 9:13 PM
RMFC stock has 5X potential, shorts at zero borrow and the 3m float is locked. Very undervalued here - No dilution - Catalysts coming - Just reported record financials and added a new store a few weeks ago. $TURB $CSBR $IVVD $CGTX $YXT watching close
2 · Reply
indievestments
indievestments Sep. 15 at 7:29 PM
$CSBR trading like they got Corellia funding. I guess we'll see tonight.
1 · Reply
S2K_TP
S2K_TP Sep. 14 at 8:52 PM
🚨 Major Monday's earnings releases: @everyone $CODA before bell $OPTT after bell $HITI after bell $PLAY after bell $CSBR after bell
0 · Reply
RadioIsotope25
RadioIsotope25 Sep. 12 at 12:33 PM
$RADX Lantheus is an aggregator in this space. $RADX $CSBR $LNTH
0 · Reply
RadioIsotope25
RadioIsotope25 Sep. 11 at 4:53 PM
$RADX Significant Radiopharma deals in 2025 $CSBR $CLRB $NVS
0 · Reply
RadioIsotope25
RadioIsotope25 Sep. 11 at 1:30 AM
$RADX “We are pleased to make a strategic investment in RAD and partner with them to further expand our innovative pipeline,” said Brian Markison, Chief Executive Officer of Lantheus. “Radiopharmaceutical theranostics are changing the way cancer is diagnosed and treated, yet we still have more work to do and are inspired to further advance this field with these two preclinical oncology assets. $LNTH $ATNM $CSBR
3 · Reply
Ned__ryerson
Ned__ryerson Aug. 26 at 9:57 PM
$CSBR this thing is starting to stink again. Oh well, I do wish they would get their shit together.
0 · Reply
indievestments
indievestments Aug. 25 at 2:50 PM
$CSBR 20k in the premarket?
0 · Reply
DigitalSigma
DigitalSigma Aug. 23 at 10:21 AM
$CSBR Champions Oncology Inc is facing preclinical research demand cyclicality
1 · Reply
Ned__ryerson
Ned__ryerson Aug. 19 at 2:55 PM
$CSBR Stock has been showing strength, does anybody know what is up?
1 · Reply
AdiDasRom
AdiDasRom Aug. 19 at 2:13 PM
$CSBR
0 · Reply
Pacol4
Pacol4 Jul. 26 at 7:59 PM
$CSBR The new CEO's equity compensation seems to be expressing confidence on the data licensing side. 70% is performance based and the lowest target is $15MN in data licensing revenue over any 12 month period. Also from the latest call they appear to be close to funding Corelia ? "And we really hope that over the next couple of months, we're going to be able to fund that company" Can someone confirm whether they have ever said something like this ?
1 · Reply
AdiDasRom
AdiDasRom Jul. 24 at 6:00 PM
$CSBR Let's be serious, because they had a slightly larger loss than estimated given that they are in various stages of research and do not yet have revenues!? Bullish
0 · Reply
AdiDasRom
AdiDasRom Jul. 24 at 2:08 PM
$CSBR very bullish
0 · Reply
HaltTradeAlert
HaltTradeAlert Jul. 24 at 1:34 PM
$CSBR Halt Time: 09:30:48 Issue Symbol: CSBR Reason Code: LUDP Members get this halt alert with no delay and with more info: last stock price, volume, shares outstanding, market cap, relative volume, and percentage change on the day. Also, halt alerts for pre-market hours and after market hours which is extremely important for Code T1 News Pending Alerts!! And free real time news catalyst alerts!
0 · Reply
JeffreyCress
JeffreyCress Jul. 23 at 8:29 PM
$CSBR great report. Lacking volume/attention.
0 · Reply
JeffreyCress
JeffreyCress Jul. 23 at 8:16 PM
$CSBR
0 · Reply
indievestments
indievestments Jul. 18 at 7:45 PM
$CSBR they finally booted Dr. Ronnie. Seems like scaling the data platform is still a few quarters away.
0 · Reply
DARKP00L
DARKP00L Jul. 18 at 12:31 PM
$CSBR 08:31 on Jul. 18 2025 Champions Oncology Appoints Rob Brainin As CEO, Effective Aug. 25 #tradeideas
0 · Reply
Rasto2020
Rasto2020 Jul. 13 at 8:36 PM
$CSBR inverted head and shoulder on daily .,
0 · Reply